CalciMedica (CALC) Total Liabilities (2019 - 2026)
CalciMedica's (CALC) quarterly Total Liabilities came in at $9.7 million in Q1 2026, down 32.82% YoY from $14.5 million in Q1 2025, and down 51.99% on a QoQ basis from $20.2 million in Q4 2025.
CalciMedica (CALC) Total Liabilities (2019 - 2026) Analysis & Trends
CalciMedica (CALC) has 8 years of Total Liabilities data on file, last reported at $9.7 million in Q1 2026.
- Quarterly Total Liabilities fell 32.82% year-over-year to $9.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.7 million (down 32.82% YoY) and the FY2025 annual result came in at $20.2 million, up 275.78% from the prior year.
- Total Liabilities fell to $9.7 million in Q1 2026, from $20.2 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $20.2 million in Q4 2025 to a low of $3.7 million in Q3 2023.
- A 5-year average of $8.9 million and a median of $7.2 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities plunged 67.99% — and 2025, when it soared 275.78%.
- Tracing CALC's Total Liabilities over 5 years: stood at $12.6 million in 2022, then sank by 67.99% to $4.0 million in 2023, then jumped by 33.66% to $5.4 million in 2024, then soared by 275.78% to $20.2 million in 2025, then slumped by 51.99% to $9.7 million in 2026.
- The last three Total Liabilities figures came in at $9.7 million (Q1 2026), $20.2 million (Q4 2025), and $15.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.20 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.35 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 10.03 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 3.22 Bn |
| 10 | CalciMedica | 9.93 Mn | -8.69 Mn | - | 13.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.99 Mn |
| Mar 31, 2026 | 9.71 Mn |
| Dec 31, 2025 | 20.23 Mn |
| Sep 30, 2025 | 15.18 Mn |
| Jun 30, 2025 | 12.98 Mn |
| Mar 31, 2025 | 14.46 Mn |
| Dec 31, 2024 | 5.38 Mn |
| Sep 30, 2024 | 7.18 Mn |
| Jun 30, 2024 | 7.21 Mn |
| Mar 31, 2024 | 9.89 Mn |
| Dec 31, 2023 | 4.03 Mn |
| Sep 30, 2023 | 3.69 Mn |
| Jun 30, 2023 | 4.02 Mn |
| Mar 31, 2023 | 12.65 Mn |
| Dec 31, 2022 | 12.58 Mn |
| Sep 30, 2022 | 3.76 Mn |
| Jun 30, 2022 | 4.33 Mn |
| Mar 31, 2022 | 4.33 Mn |
| Dec 31, 2021 | 4.07 Mn |
| Sep 30, 2021 | 4.50 Mn |